Clinical effectiveness of steroid treatment on lung function and immunologic markers in pulmonary sarcoidosis

O. Tolokh, A. Ladnyy, N. Rudnicka (Lviv, Ukraine)

Source: Annual Congress 2007 - Granulomatous lung diseases including sarcoidosis
Session: Granulomatous lung diseases including sarcoidosis
Session type: Thematic Poster Session
Number: 647
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Tolokh, A. Ladnyy, N. Rudnicka (Lviv, Ukraine). Clinical effectiveness of steroid treatment on lung function and immunologic markers in pulmonary sarcoidosis. Eur Respir J 2007; 30: Suppl. 51, 647

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical characteristics and pulmonary function in patients with pulmonary fibrosis assessed for lung transplant
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010


The effectiveness of pulmonary rehabilitation in interstitial lung diseases in terms of functional markers
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

Clinical profile of idiopathic pulmonary fibrosis with lung cancer
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011


Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019

Clinical and radiological variants of fibrosis pulmonary sarcoidosis
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020


Clinical and morphological signs of liver damadge in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease
Source: Eur Respir Rev, 27 (148) 170102; 10.1183/16000617.0102-2017
Year: 2018



Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia
Source: Eur Respir J 2009; 33: 68-76
Year: 2009



Comprehensive evaluation of airway involvement in pulmonary sarcoidosis
Source: ERJ Open Res, 3 (1) 00105-2016; 10.1183/23120541.00105-2016
Year: 2017



Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012

Efficacy of pulmonary rehabilitation in patients with interstitial lung disease
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012


Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
Source: Eur Respir J, 54 (6) 1901188; 10.1183/13993003.01188-2019
Year: 2019



Markers of resistance to corticosteroids therapy in patients with pulmonary sarcoidosis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Clinical characteristics, haemodynamics, and survival in patients with combined pulmonary fibrosis and emphysema and associated pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008

Evolution of systemic response in patients with pulmonary sarcoidosis of different course of the disease during anti-inflammatory treatment
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009

Safety of corticosteroid therapy in patients with pulmonary sarcoidosis
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017


The clinical relevance of autoimmunity in idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012

Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 15s
Year: 2002

Clinical and morphological outcomes of pulmonary tuberculosis concurrent with chronic hepatitis
Source: Eur Respir J 2006; 28: Suppl. 50, 13s
Year: 2006

Clinical features of combined pulmonary fibrosis and emphysema
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010